Director, Direct-to-Customer (DTC) Innovation & Digital Health
BeiGene
Summary
BeOne Medicines is seeking an experienced, entrepreneurial Director / Senior Director, Direct-to-Customer (DTC) Innovation & Digital Health to lead the development and launch of innovative customer engagement experiences across the hematology portfolio, with an initial focus on follicular lymphoma (FL), marginal zone lymphoma (MZL), and Waldenström macroglobulinemia (WM). The role translates hematology strategy and customer insights into integrated, end-to-end experiences, including digital campaigns, disease-state microsites, CRM journeys, content ecosystems, digital health solutions, and clinical-trial awareness initiatives.
Job description
Essential Functions of the Job
Lead FL, MZL and WM customer experience launches
- Own the strategy, development, and launch of integrated customer experiences for FL, MZL, and WM, including disease-state microsites, campaigns, CRM journeys, and supporting digital experiences.
- Translate disease insights, treatment journeys, unmet needs, and portfolio priorities into engagement strategies for patients, caregivers, and healthcare professionals.
- Determine when experiences should be disease-specific versus modular or shared across hematologic malignancies.
- Establish launch roadmaps, milestones, dependencies, governance, and success measures from concept through approval, deployment, and optimization.
Build integrated campaigns and content ecosystems
- Lead development and activation of branded and unbranded digital campaigns across priority hematology indications.
- Develop customer-first strategies spanning paid media, search, social, AI-enabled channels, point-of-care channels, and emerging platforms.
- Partner with Brand and cross-functional stakeholders so DTC initiatives complement broader commercial strategy with clear ownership and governance.
- Oversee agency and external partner work from strategic brief through creative development, regulatory review, production, activation, and optimization.
- Apply continuous improvement based on customer behavior, channel performance, business priorities, and emerging market opportunities.
Lead CRM strategy and customer journeys
- Design and launch CRM journeys for FL, MZL, and WM, connecting site experiences, content, media, and opt-in engagement into cohesive longitudinal customer journeys.
- Define audience segmentation, journey logic, triggers, content requirements, and measurement plans with CRM, analytics, technology, privacy, and agency partners.
- Use first-party data and behavioral insights to progressively personalize engagement and improve content relevance.
- Help evolve CRM from standalone communications into an integrated capability connecting multiple patient and customer touchpoints.
Advance digital health innovation
- Identify and lead digital health enablements that improve patient and HCP experiences across the hematology journey.
- Evaluate emerging technologies and partners and rapidly translate promising concepts into testable pilots.
- Explore AI-enabled experiences, personalization, decision-support tools, and other technologies that reduce friction and improve access to relevant information.
- Build business cases and measurement frameworks for new capabilities, balancing innovation with feasibility, compliance, privacy, and scalability.
Support clinical-trial awareness and digital recruitment innovation
- Partner with Clinical Operations, Medical, R&D, and other stakeholders to develop digital clinical-trial awareness initiatives for priority hematology studies.
- Develop compliant approaches to increase awareness of actively recruiting trials among appropriate HCP and patient audiences.
- Explore opportunities to connect disease education, CRM, digital platforms, media, and trial-finding experiences.
- Establish practical measurement approaches, including engagement, search behavior, referral indicators, and downstream enrollment signals where feasible.
Drive cross-functional execution
- Serve as a connector across Commercial, Medical, Clinical Operations, Corporate Affairs, Legal, Regulatory/PRC, Analytics, Technology, Privacy, and external agencies.
- Navigate regulatory requirements associated with branded, unbranded, disease-awareness, and clinical-trial communications.
- Build strong partnerships with hematology Brand teams while identifying opportunities to test new approaches and accelerate execution.
- Provide clear recommendations to senior leaders, simplify complex decisions, and maintain momentum as priorities or inputs change.
- Act with a high degree of autonomy and ownership while escalating material business, regulatory, privacy, or operational risks appropriately.
Build a measurement and optimization discipline
- Define launch KPIs across awareness, engagement, CRM enrollment, journey progression, media performance, customer behavior, and business impact.
- Partner with Analytics to connect channel-level engagement to meaningful downstream customer behaviors wherever feasible.
- Use test-and-learn methodologies to identify effective audiences, messages, journeys, and channels and rapidly adjust programs based on results.
- Communicate performance, insights, risks, and recommendations clearly to senior leadership.
Qualifications
Required
- Bachelor's degree required; advanced degree preferred.
- Significant pharmaceutical, biotechnology, or healthcare marketing/customer-experience experience, with direct hematology experience required.
- Strong working knowledge of the hematology/oncology treatment landscape, with experience in B-cell malignancies strongly preferred.
- Demonstrated experience launching digital campaigns, websites or microsites, CRM programs, or integrated omnichannel experiences in a regulated healthcare environment.
- Experience taking complex initiatives from strategy through content development, regulatory/MLR or PRC review, production, launch, and optimization.
- Strong understanding of pharmaceutical regulatory, privacy, and compliance considerations affecting patient and HCP engagement.
- Demonstrated success in a fast-paced, highly dynamic environment with multiple simultaneous priorities and aggressive launch timelines.
- Exceptional cross-functional leadership, stakeholder-management, and agency-management skills.
- Strong strategic thinking coupled with a willingness to be hands-on in execution.
- Excellent written and verbal communication skills, with the ability to simplify complex clinical, technical, and strategic information.
Preferred
- Direct experience in FL, MZL, WM, CLL/SLL, or related B-cell malignancies.
- Experience building patient disease-education platforms, digital patient communities, or HCP education ecosystems.
- CRM experience, ideally including Salesforce Marketing Cloud, patient journey design, segmentation, consent management, and personalization.
- Experience with HCP digital/point-of-care platforms, paid media, search, and social activation.
- Experience with digital health, AI-enabled customer experiences, or emerging healthcare technologies.
- Clinical-trial recruitment or clinical-trial awareness experience.
- Experience using analytics, experimentation, and customer-level data to optimize marketing or digital-health initiatives.
- Experience managing agencies, vendors, budgets, and multiple simultaneous workstreams.
Computer Skills
CRM platforms (ideally Salesforce Marketing Cloud), digital campaign and microsite environments, analytics and measurement platforms, paid media/search/social channels, AI-enabled tools, and related healthcare technology platforms.
Other Qualifications
Leadership profile: A builder; hematology fluent; customer obsessed; digitally sophisticated; fast and pragmatic; commercially minded; highly collaborative; and comfortable switching altitude between executive strategy and detailed execution.
Supervisory responsibilities: May lead direct reports and/or manage cross-functional teams, agency teams, contractors, and matrixed partners. Final structure will depend on level and organizational design.
Travel: Approximately 20%, based on business needs.
Requirements
- Bachelor's degree required
- Significant pharmaceutical, biotechnology, or healthcare marketing/customer-experience experience
- Direct hematology experience required
- Strong working knowledge of the hematology/oncology treatment landscape
- Demonstrated experience launching digital campaigns, websites or microsites, CRM programs, or integrated omnichannel experiences in a regulated healthcare environment
- Experience taking complex initiatives from strategy through content development, regulatory/MLR or PRC review, production, launch, and optimization
- Strong understanding of pharmaceutical regulatory, privacy, and compliance considerations affecting patient and HCP engagement
- Demonstrated success in a fast-paced, highly dynamic environment with multiple simultaneous priorities and aggressive launch timelines
- Exceptional cross-functional leadership, stakeholder-management, and agency-management skills
- Strong strategic thinking coupled with a willingness to be hands-on in execution
- Excellent written and verbal communication skills
- CRM platforms (ideally Salesforce Marketing Cloud)
- Digital campaign and microsite environments
- Analytics and measurement platforms
- Paid media/search/social channels
- AI-enabled tools
Benefits
- Medical, Dental & Vision
- 401(k)
- FSA/HSA
- Life Insurance
- Paid Time Off
- Wellness
- Annual Bonus Plan
- Incentive Compensation Plan
- Discretionary Equity Awards
- Employee Stock Purchase Plan
Company overview
BeiGene, Ltd., now rebranding as BeOne Medicines, is a global commercial-stage biotechnology company specializing in the discovery, development, manufacturing, and commercialization of innovative oncology medicines. Founded in 2010 by John V. Oyler and Xiaodong Wang, the company has grown into a multinational organization with headquarters in Cambridge, Massachusetts, Beijing, China, and Basel, Switzerland. BeiGene focuses on developing targeted and immune-oncology therapies for cancer treatment, with a diverse pipeline that includes internally discovered products like BRUKINSA (zanubrutinib), a Bruton's tyrosine kinase inhibitor, and Tevimbra (tislelizumab), a PD-1 inhibitor. The company operates across six continents with over 45 countries participating in clinical trials and has enrolled more than 30,000 patients in its research programs. With approximately 12,000 employees worldwide, BeiGene has established itself as a significant player in global oncology, particularly with strong market presence in China and expanding operations in the United States and Europe. The company's mission centers on expanding access to high-quality cancer therapies worldwide through persistent innovation and challenging traditional approaches to drug development.